NCT07498309: Evaluation of the Efficacy of Iloprost in the Management of Vaso-occlusive Crises in Adult Patients With Sickle Cell Disease
- State
- Not started
- Phase
- Phase 3
- People
- 144 planned
- Started
- Sep 2026
- Primary completion
- Mar 2030
- Arms
- Iloprost
- Results
- None posted
- 27 Mar 2026: Trial registered